Department of Neurology, University of Ulm, Ulm, Germany.
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Neuroimage Clin. 2024;43:103633. doi: 10.1016/j.nicl.2024.103633. Epub 2024 Jun 14.
The corticospinal tract (CST) reveals progressive microstructural alterations in ALS measurable by DTI. The aim of this study was to evaluate fractional anisotropy (FA) along the CST as a longitudinal marker of disease progression in ALS.
The study cohort consisted of 114 patients with ALS and 110 healthy controls from the second prospective, longitudinal, multicentre study of the Canadian ALS Neuroimaging Consortium (CALSNIC-2). DTI and clinical data from a harmonized protocol across 7 centres were collected. Thirty-nine ALS patients and 61 controls completed baseline and two follow-up visits and were included for longitudinal analyses. Whole brain-based spatial statistics and hypothesis-guided tract-of-interest analyses were performed for cross-sectional and longitudinal analyses.
FA was reduced at baseline and longitudinally in the CST, mid-corpus callosum (CC), frontal lobe, and other ALS-related tracts, with alterations most evident in the CST and mid-CC. CST and pontine FA correlated with functional impairment (ALSFRS-R), upper motor neuron function, and clinical disease progression rate. Reduction in FA was largely located in the upper CST; however, the longitudinal decline was greatest in the lower CST. Effect sizes were dependent on region, resulting in study group sizes between 17 and 31 per group over a 9-month interval. Cross-sectional effect sizes were maximal in the upper CST; whereas, longitudinal effect sizes were maximal in mid-callosal tracts.
Progressive microstructural alterations in ALS are most prominent in the CST and CC. DTI can provide a biomarker of cerebral degeneration in ALS, with longitudinal changes in white matter demonstrable over a reasonable observation period, with a feasible number of participants, and within a multicentre framework.
皮质脊髓束(CST)在 ALS 中可通过 DTI 测量到进行性的微观结构改变。本研究旨在评估 CST 中的各向异性分数(FA)作为 ALS 疾病进展的纵向标志物。
研究队列包括来自加拿大 ALS 神经影像学联合会(CALSNIC-2)的第二个前瞻性、纵向、多中心研究的 114 名 ALS 患者和 110 名健康对照者。在 7 个中心采用统一方案收集了 DTI 和临床数据。39 名 ALS 患者和 61 名对照者完成了基线和两次随访,纳入进行纵向分析。进行了全脑基于空间的统计学和基于假设的感兴趣区分析,用于横断面和纵向分析。
在基线和纵向时,CST、胼胝体中部(CC)、额叶和其他与 ALS 相关的束中 FA 降低,CST 和 CC 中部的改变最为明显。CST 和脑桥 FA 与功能障碍(ALSFRS-R)、上运动神经元功能和临床疾病进展率相关。FA 的降低主要位于 CST 的上部;然而,纵向下降在 CST 的下部最大。效应大小取决于区域,导致在 9 个月的时间间隔内,每组的研究人数为 17 至 31 人。横断面效应大小在 CST 的上部最大;而纵向效应大小在胼胝体中部最大。
ALS 中的进行性微观结构改变在 CST 和 CC 中最为明显。DTI 可提供 ALS 脑退化的生物标志物,在合理的观察期内可显示白质的纵向变化,参与者数量可行,并且可以在多中心框架内进行。